Unlocking Potential: Investment Opportunities in the Pharmaceutical Excipient Market By 2024 to 2034 from Sanket Badgujar's blog

The global pharmaceutical excipient market is slated to have a valuation of US$ 972.9 million in 2024. The burgeoning pharmaceutical industry is playing into the hands of pharmaceutical excipient vendors. With governments especially desirous of extending healthcare services to rural and remote parts, the pharmaceutical sector, and in turn, the pharmaceutical excipient market, is benefitting.

The pharmaceutical excipient industry is slated to progress at a CAGR of 5.1% through 2034. Excipients are moving away from the non-active role they were traditionally playing. Functional and novel excipients often provide functions like changing the color of the medicine or enhancing the effect of the active ingredient. Thus, pharmaceutical excipients are getting more of the limelight and end-users are paying more attention to them.

Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-932

By the time 2034 rolls around, the pharmaceutical excipient market’s value is forecasted to hit US$ 1,600 million. Development in the biologics sector is expected to add considerable value to the market. Similarly, developments in nanotechnology are predicted to enhance market value during the forecast period.

Some factors slow down the growth of the market. The market is heavily regulated, and the launch of new products has the potential to be slow as holdups from regulatory authorities are common. As with many pharmaceutical ingredients, consumer aversion towards them, especially artificial ingredients, is a roadblock for the market.

“Use of excipients to mask the taste of bitter medicines or to provide a different color to them is anticipated to help in the market’s progress. Despite the existence of some notable drawbacks, the multi-functionality of excipients is expected to help the market to progress along nicely,” says an analyst at FMI.

Key Takeaways from the Pharmaceutical Excipient Market:

• The pharmaceutical excipient market is expected to be US$ 9 million in size in 2024.
• Artificial excipients rule the roost in the market. Artificial excipients are expected to account for 34.7% of the market share in 2024.  
• Coating is the predominant technique. For 2024, coating is anticipated to account for 33.0% of the market share.
• China is expected to be a promising country in terms of progress for the market. The country is forecasted to have a CAGR of 5.6% from 2024 to 2034 in the market.
• The United States and Japan are poised to be lucrative countries for the market. For the forecast period, the CAGR for both the United States and Japan is predicted to be 5.3%.
• The market is expected to progress at a CAGR of 5.4% in Germany.

Competition Analysis of the Pharmaceutical Excipient Market:

The pharmaceutical excipient market is fragmented, with small-scale companies looking at product differentiation. While bigger companies look to expand production capabilities.

Recent Developments in the Pharmaceutical Excipient Market:

• In October 2023, Clariant Chemicals introduced three new excipients as part of its VitiPure range.
• In November 2021, Gattefossé unveiled excipients named Labrafac MC60, Gelucire 59/14, and Emulfree Duo.

Key Companies in the Pharmaceutical Excipient Market:

• Ashland Global Holdings
• Croda International
• BASF SE
• Lubrizol Corporation
• Evonik Industries AG
• Associated British Foods
• Roquette Feres
• Archer Daniels Midland Company
• DuPont
• Avantor Performance Materials, Inc.
• The Dow Chemical Company
• FMC Corporation
• Evonik Industries
• Lubrizol Corporation
• Roquette
• Colorcon, Inc.

Key Segments:

By Type:

• Organic Chemicals
• Oleochemicals
• Fatty Alcohols
• Mineral Stearates
• Glycerin
• Other Oleochemicals
• Carbohydrates
• Sugars
• Actual Sugars
• Sugar Alcohols
• Artificial Sweeteners
• Cellulose
• Microcrystalline cellulose
• Cellulose ethers
• Carboxymethyl cellulose (CMC) and croscarmellose sodium
• Cellulose esters
• Starch
• Modified Starch
• Dried Starch
• Converted Starch
• Petrochemicals
• Glycols
• Povidones
• Mineral Hydrocarbons
• Acrylic Polymers
• Other Petrochemical Excipients
• Proteins
• Other Organic Chemicals
• Artificial
• Calcium Phosphate
• Metal Oxides
• Halites
• Calcium Carbonate
• Calcium Sulphate
• Other Artificial Chemicals
• Other Chemicals

By Technique:

• Fillers & Diluents
• Suspending & Viscosity
• Coating
• Binders
• Flavoring & Sweeteners
• Disintegrants
• Colorants
• Lubricants & Glidants
• Preservatives
• Emulsifying

By Formulation:

• Oral Formulations
• Tablets
• Capsules
• Hard-gelatin Capsules
• Soft-gelatin Capsules
• Liquid Formulations
• Other Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Formulations

By Application:

• Taste Masking
• Stabilizers
• Modified-Release
• Solubility & Bioavailability Enhancement
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)